Home » Topics » BioWorld Science

BioWorld Science
RSS

RefleXion and Telix to study combining technologies for prostate and renal cancers

July 9, 2020

New phase II study evaluates RUC-4 in patients with STEMI

July 9, 2020

Numab begins first-in-human study of NM21-1480 for advanced solid tumors

July 9, 2020

Constant's TXA-127 to be studied for COVID-19 in phase II trials

July 9, 2020

Reverie and Roche establish multi-target collaboration

July 9, 2020

Asieris cleared in China to begin global phase III trial of Cevira for high-grade cervical dysplasia

July 9, 2020

FDA approves IND for phase I/IIa study of FCR-001 for diffuse systemic sclerosis

July 9, 2020

Indivior begins first-in-human study of INDV-2000 for opioid dependence

July 9, 2020

Enrollment completed in phase II study of mRNA-1273 for COVID-19

July 9, 2020

DECR1 unveiled as a potential therapeutic target in prostate cancer

July 9, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...